{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:56:30Z","timestamp":1790142990979,"version":"4.0.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T00:00:00Z","timestamp":1352764800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2458-12-974","type":"journal-article","created":{"date-parts":[[2012,11,13]],"date-time":"2012-11-13T21:14:12Z","timestamp":1352841252000},"source":"Crossref","is-referenced-by-count":92,"title":["Incidence and survival in non-hereditary amyloidosis in Sweden"],"prefix":"10.1186","volume":"12","author":[{"given":"Kari","family":"Hemminki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinjun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asta","family":"F\u00f6rsti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Sundquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,13]]},"reference":[{"issue":"3\u20134","key":"4517_CR1","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/13506129.2010.526812","volume":"17","author":"JD Sipe","year":"2010","unstructured":"Sipe JD, Benson MD, Buxbaum JN, Ikeda S, Merlini G, Saraiva MJ, Westermark P: Amyloid fibril protein nomenclature: 2010 recommendations from the nomenclature committee of the International Society of Amyloidosis. Amyloid. 2010, 17 (3\u20134): 101-104.","journal-title":"Amyloid"},{"key":"4517_CR2","first-page":"181","volume":"86","author":"M Gertz","year":"2011","unstructured":"Gertz M: Immunoglobin light chain amyloidosis: 2011 update on diagnosis, risk-stratification, and management. Am J Hematol. 2011, 86: 181-186.","journal-title":"Am J Hematol"},{"key":"4517_CR3","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1016\/j.semarthrit.2008.09.001","volume":"39","author":"T Pettersson","year":"2010","unstructured":"Pettersson T, Konttinen YT: Amyloidosis-recent developments. Semin Arthritis Rheu. 2010, 39: 356-368. 10.1016\/j.semarthrit.2008.09.001.","journal-title":"Semin Arthritis Rheu"},{"key":"4517_CR4","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1200\/JCO.2010.32.2271","volume":"29","author":"G Merlini","year":"2011","unstructured":"Merlini G, Seldin DC, Gertz MA: Amyloidosis: pathogenesis and new therapeutic options. J Clin Oncol. 2011, 29: 1924-1933. 10.1200\/JCO.2010.32.2271.","journal-title":"J Clin Oncol"},{"key":"4517_CR5","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/07853890701206887","volume":"39","author":"V Bellotti","year":"2007","unstructured":"Bellotti V, Nuvolone M, Giorgetti S, Obici L, Palladini G, Russo P, Lavatelli F, Perfetti V, Merlini G: The workings of the amyloid diseases. Ann Med. 2007, 39: 200-207. 10.1080\/07853890701206887.","journal-title":"Ann Med"},{"key":"4517_CR6","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.coph.2005.10.005","volume":"6","author":"HJ Lachmann","year":"2006","unstructured":"Lachmann HJ, Hawkins PN: Systemic amyloidosis. Curr Opin Pharmacol. 2006, 6: 214-220. 10.1016\/j.coph.2005.10.005.","journal-title":"Curr Opin Pharmacol"},{"key":"4517_CR7","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1002\/art.24735","volume":"61","author":"L Obici","year":"2009","unstructured":"Obici L, Raimondi S, Lavatelli F, Bellotti V, Merlini G: Susceptibility to AA amyloidosis in rheumatic diseases: a critical overview. Arthritis Rheum. 2009, 61: 1435-1440. 10.1002\/art.24735.","journal-title":"Arthritis Rheum"},{"key":"4517_CR8","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1080\/13506120802524676","volume":"15","author":"R Koivuniemi","year":"2008","unstructured":"Koivuniemi R, Paimela L, Suomalainen R, Tornroth T, Leirisalo-Repo M: Amyloidosis is frequently undetected in patients with rheumatoid arthritis. Amyloid. 2008, 15: 262-268. 10.1080\/13506120802524676.","journal-title":"Amyloid"},{"key":"4517_CR9","first-page":"408","volume":"26","author":"R Koivuniemi","year":"2008","unstructured":"Koivuniemi R, Paimela L, Suomalainen R, Leirisalo-Repo M: Amyloidosis as a cause of death in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2008, 26: 408-413.","journal-title":"Clin Exp Rheumatol"},{"key":"4517_CR10","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1093\/rheumatology\/38.6.499","volume":"38","author":"R Myllykangas-Luosujarvi","year":"1999","unstructured":"Myllykangas-Luosujarvi R, Aho K, Kautiainen H, Hakala M: Amyloidosis in a nationwide series of 1666 subjects with rheumatoid arthritis who died during 1989 in Finland. Rheumatology (Oxford). 1999, 38: 499-503. 10.1093\/rheumatology\/38.6.499.","journal-title":"Rheumatology (Oxford)"},{"key":"4517_CR11","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/03009741003747481","volume":"39","author":"M Vasala","year":"2010","unstructured":"Vasala M, Immonen K, Kautiainen H, Hakala M: More evidence of declining incidence of amyloidosis associated with inflammatory rheumatic diseases. Scand J Rheumatol. 2010, 39: 461-465. 10.3109\/03009741003747481.","journal-title":"Scand J Rheumatol"},{"key":"4517_CR12","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1016\/j.berh.2003.09.001","volume":"17","author":"MD Benson","year":"2003","unstructured":"Benson MD: The hereditary amyloidoses. Best Pract Res Clin Rheumatol. 2003, 17: 909-927. 10.1016\/j.berh.2003.09.001.","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"4517_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1046\/j.1365-2796.2003.01173.x","volume":"254","author":"OB Suhr","year":"2003","unstructured":"Suhr OB, Svendsen IH, Andersson R, Danielsson A, Holmgren G, Ranlov PJ: Hereditary transthyretin amyloidosis from a Scandinavian perspective. J Intern Med. 2003, 254: 225-235. 10.1046\/j.1365-2796.2003.01173.x.","journal-title":"J Intern Med"},{"key":"4517_CR14","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1056\/NEJMra023144","volume":"349","author":"G Merlini","year":"2003","unstructured":"Merlini G, Bellotti V: Molecular mechanisms of amyloidosis. N Engl J Med. 2003, 349: 583-596. 10.1056\/NEJMra023144.","journal-title":"N Engl J Med"},{"key":"4517_CR15","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.beha.2007.08.001","volume":"20","author":"RA Kyle","year":"2007","unstructured":"Kyle RA, Rajkumar SV: Epidemiology of the plasma-cell disorders. Best Pract Res Clin Haematol. 2007, 20: 637-664. 10.1016\/j.beha.2007.08.001.","journal-title":"Best Pract Res Clin Haematol"},{"key":"4517_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s00277-010-1028-8","volume":"90","author":"S Siragusa","year":"2011","unstructured":"Siragusa S, Morice W, Gertz MA, Kyle RA, Greipp PR, Lust JA, Witzig TE, Lacy MQ, Zeldenrust SR, Rajkumar SV, et al: Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature. Ann Hematol. 2011, 90: 101-106. 10.1007\/s00277-010-1028-8.","journal-title":"Ann Hematol"},{"key":"4517_CR17","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1182\/blood.V79.7.1817.1817","volume":"79","author":"RA Kyle","year":"1992","unstructured":"Kyle RA, Linos A, Beard CM, Linke RP, Gertz MA, O'Fallon WM, Kurland LT: Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood. 1992, 79: 1817-1822.","journal-title":"Blood"},{"key":"4517_CR18","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, Heurgren M, Olausson PO: External review and validation of the Swedish national inpatient register. BMC Public Health. 2011, 11: 450-10.1186\/1471-2458-11-450.","journal-title":"BMC Public Health"},{"key":"4517_CR19","first-page":"258","volume-title":"Causes of death 2010","author":"Socialstyrelsen","year":"2011","unstructured":"Socialstyrelsen: Causes of death 2010. 2011, Stockholm: National Board of Health and Welfare, 258-"},{"key":"4517_CR20","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1056\/NEJMoa013354","volume":"346","author":"HJ Lachmann","year":"2002","unstructured":"Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN: Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med. 2002, 346: 1786-1791. 10.1056\/NEJMoa013354.","journal-title":"N Engl J Med"},{"key":"4517_CR21","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1200\/JCO.2006.09.0100","volume":"25","author":"SY Kristinsson","year":"2007","unstructured":"Kristinsson SY, Landgren O, Dickman PW, Derolf AR, Bjorkholm M: Patterns of survival in multiple myeloma: a population-based study of patients diagnosed in Sweden from 1973 to 2003. J Clin Oncol. 2007, 25: 1993-1999. 10.1200\/JCO.2006.09.0100.","journal-title":"J Clin Oncol"},{"key":"4517_CR22","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/art.24328","volume":"60","author":"K Hemminki","year":"2009","unstructured":"Hemminki K, Li X, Sundquist J, Sundquist K: Familial associations of rheumatoid arthritis with autoimmune disorders and related conditions. Arthritis Rheum. 2009, 60: 661-668. 10.1002\/art.24328.","journal-title":"Arthritis Rheum"},{"key":"4517_CR23","doi-asserted-by":"publisher","first-page":"2361","DOI":"10.1056\/NEJMoa070265","volume":"356","author":"HJ Lachmann","year":"2007","unstructured":"Lachmann HJ, Goodman HJ, Gilbertson JA, Gallimore JR, Sabin CA, Gillmore JD, Hawkins PN: Natural history and outcome in systemic AA amyloidosis. N Engl J Med. 2007, 356: 2361-2371. 10.1056\/NEJMoa070265.","journal-title":"N Engl J Med"},{"key":"4517_CR24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3109\/13506129.2010.549252","volume":"18","author":"K Immonen","year":"2011","unstructured":"Immonen K, Finne P, Gronhagen-Riska C, Pettersson T, Klaukka T, Kautiainen H, Hakala M: A marked decline in the incidence of renal replacement therapy for amyloidosis associated with inflammatory rheumatic diseases \u2013 data from nationwide registries in Finland. Amyloid-Journal of Protein Folding Disorders. 2011, 18: 25-28. 10.3109\/13506129.2010.549252.","journal-title":"Amyloid-Journal of Protein Folding Disorders"},{"key":"4517_CR25","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1080\/13506120701460923","volume":"14","author":"P Westermark","year":"2007","unstructured":"Westermark P, Benson MD, Buxbaum JN, Cohen AS, Frangione B, Ikeda S, Masters CL, Merlini G, Saraiva MJ, Sipe JD: A primer of amyloid nomenclature. Amyloid. 2007, 14: 179-183. 10.1080\/13506120701460923.","journal-title":"Amyloid"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-12-974\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-974.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-12-974.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T02:42:44Z","timestamp":1594867364000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-12-974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,13]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["4517"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-12-974","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,13]]},"article-number":"974"}}